Revolutionize The Way Drugs Are Discovered & Developed

Currently, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. At Verge Genomics, we believe there is a better way: we aim to improve the traditional drug discovery process with approaches based on systems biology, machine learning on human patient data, and drug screening in human cell cultures.

We’ve raised $32 million in Series A financing to build a next-generation biopharmaceutical company focused on accelerating development of life-saving treatments for patients with neurodegenerative diseases, including ALS, Parkinson’s Disease, and Alzheimer’s Disease.



  • Patient Driven  - Inspired and driven by the people who need us ♥️⚕💊

  • Team of Founders - We are each responsible for the success of the company and each other 🗝🦅

  • Transparency - Express ourselves with candor 🌤

  • Growth Mindset - Always seeking opportunities to improve 🌱

  • Grit - Persevere in the face of adversity 💪

  • Rigor - Supporting quality science 🔬

More About You

As an emerging startup, Verge Genomics provides growth opportunities into other areas of the company. Being one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. You will be empowered to own your work and makes real decisions.

In addition to competitive compensation and benefits, we offer perks like unlimited vacation/sick days, and free lunch delivered every day.